Project Details
Description
Oral Carbon Monoxide Therapeutic to Prevent Sickle Cell Crisis
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/16 → 6/30/17 |
Funding
- HILLHURST BIOPHARMACEUTICALS, INC
- NIH NATL HEART, LUNG AND BLOOD INSTITU
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.